| Literature DB >> 35434127 |
Ali Asghari1, Bahareh Kordi2, Bahman Maleki3, Hamidreza Majidiani2, Morteza Shams4, Razi Naserifar4.
Abstract
Vaccination is a standout preventive measure to combat neosporosis among cattle herds. The present in silico study was done to evaluate the physicochemical properties and potent immunogenic epitopes of N. caninum SRS2 protein as a possible vaccine candidate. Web-based tools were used to predict physicochemical properties, antigenicity, allergenicity, solubility, posttranslational modification (PTM) sites, transmembrane domains and signal peptide, and secondary and tertiary structures as well as intrinsically disordered regions, followed by identification and screening of potential linear and conformational B-cell epitopes and those peptides having affinity to bind mouse major histocompatibility complex (MHC) and cytotoxic T lymphocyte (CTL). The protein had 401 residues with a molecular weight of 42 kDa, representing aliphatic index of 69.35 (thermotolerant) and GRAVY score of -0.294 (hydrophilic). There were 53 PTM sites without a signal peptide in the sequence. Secondary structure comprised mostly by extended strand, followed by helices and coils. The Ramachandran plot of the refined model showed 90.2%, 8.8%, 0.5%, and 0.5% residues in the favored, additional allowed, generously allowed, and disallowed regions, correspondingly. Additionally, various potential B-cell (linear and conformational), CTL, and MHC-binding epitopes were predicted for N. caninum SRS2. These epitopes could be further utilized in the multiepitope vaccine constructs directed against neosporosis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35434127 PMCID: PMC9007667 DOI: 10.1155/2022/7070144
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Computed solubility (a) and subcellular localization (b) of the NcSRS2 protein.
Figure 2Secondary structure prediction by PSIPRED server showing the predominance of extended strand.
Figure 3NcSRS2 protein homology modelling and refinement validation using the Ramachandran analysis. (a) The final tertiary model of NcSRS2 provided by SWISS-MODEL web server, as shown in ribbon. (b) Ramachandran plot analysis of the crude model using PROCHECK demonstrated that 82.9%, 15.6%, 1.5%, and 0.0% of residues are assigned to most favored, additional allowed, generously allowed, and disallowed areas, respectively. (c) Upon refinement, these parameters were improved to 90.2%, 8.8%, 0.5%, and 0.5%, respectively.
The final screening of shared linear B-cell epitopes from N. caninum SRS2.
| Shared B-cell epitopes | VaxiJen antigenicity score | AllergenFP allergenicity prediction | PepCalc water solubility prediction |
|---|---|---|---|
| VAKPAGAGSN | 1.1244 | Yes | Good |
| ECKERPYSAVFPGF∗ | 1.3682 | No | Good |
| VNRSVSVFA | 0.0040 | Yes | Poor |
| VALVYDSQHSIT | 0.6158 | No | Poor |
| FSSSFWTGEASGVA | 1.2775 | No | Poor |
| KADAACFAKLSASQ | -0.0772 | No | Good |
| GPDGKAFPDDY∗ | 1.6063 | No | Good |
| NNGVTLICGPD | -0.3786 | No | Poor |
| KAGKNVCLL | 0.4119 | Yes | Good |
∗ indicates antigenic, non-allergenic epitopes with potential good water solubility.
Specific B-cell linear epitopes of N. caninum SRS2 based on different physicochemical parameters predicted by the Bcepred web server.
| Physicochemical parameter | Linear B-cell epitopes |
|---|---|
| Hydrophilicity | FKSENEKF, PKQGNADQ, ACDGGTP, VCNESDGEDECEKNAA, GCKAGKN, VQSRESEV, TVNPENNGV, CGPDGKA, ELDECKERP, GCTGHPDDKQVTC, GAGSNPGGGSQPDQSSEKRDGEQVNKGKPPTGGSGGATTGKQNASQNAKDKGETGGENGDSPV, and RGDACDE |
|
| |
| Flexibility | LTAKSVN, APFKSEN, IVCNESDGE, NVYVQSRES, ITVNPEN, TELDECK, AVFPGFS, and AGAGSNPGGGSQPDQSSEKRDGEQVNKGKPPTGGSGGATTGKQNASQNAKDKGETGGENGD |
|
| |
| Accessibility | VVRRKADAA, TAKSVNRS, APFKSENEKFTC, PKQGNADQ, KLLSEDD, NESDGEDECEKNA, LPGAKKEWVTG, TIPDEHYPATSKA, YVQSRESEV, SNVRLRP, TVNPENNGV, KAFPDDYMNHH, TELDECKERPYSAV, LTIPKDQFPST, TGHPDDKQVT, GGSQPDQSSEKRDGEQVNKGKPPTGGS, and ATTGKQNASQNAKDKGETGGENGDSP |
|
| |
| Turns | NPENNGV, DYMNHHCTE |
|
| |
| Exposed surface | FKSENEKF, EDECEKN, DECKERPYSA, PDQSSEKRDGEQVNKGKPPT, and KQNASQNAKDKGE |
|
| |
| Polarity | HACVVRRKADAA, PFKSENEKFTC, KLLSEDD, NESDGEDECEKNAA, PGAKKEWVTG, VQSRESEVIG, DDYMNHHCTELDECKERPYSA, TGHPDDKQV, NIEEVAK, DQSSEKRDGEQVNKGK, NAKDKGETG, and RGDACDE |
|
| |
| Antigenic propensity | VNRSVSV, LLFGVVLAVGV, FTCLPKQ, LVYDSQH, PLPSKLLS, DDGLIVCNES, PLSTFLP, GKNVCLLNVYVQSRESEVIGQV, NGVTLICGP, QTIYLGCTG, DKQVTCVVPVNIE, and CDELPSY |
Figure 4Predicted conformational B-cell epitopes of NcSRS2 using ElliPro tool of IEDB server. Length and score of each epitope were as follows: (1) 34 residues, score: 0.713; (2) 46 residues, score: 0.705; (3) 42 residues, score: 0.666; and (4) 16 residues, score: 0.657.
Prediction of mouse MHC-I-binding epitopes of N. caninum SRS2 using IEDB server followed by antigenicity, allergenicity, and toxicity screening.
| Mouse MHC-I alleles | Position | T-cell peptide | Percentile rank | VaxiJen antigenicity score | AllergenFP allergenicity prediction | ToxinPred toxicity prediction |
|---|---|---|---|---|---|---|
| H2-Db | 24-35 | ITVNPENNGVTL∗ | 0.61 | 1.3534 | No | Nontoxin |
| 44-55 | VGCKAGKNVCLL | 5.4 | 0.2220 | Yes | Toxin | |
| 4-15 | YSAVFPGFSSSF | 5.4 | 0.4492 | No | Nontoxin | |
| 47-58 | KAGKNVCLLNVY | 6.7 | -0.0962 | No | Toxin | |
| 10-21 | VAHCAYSSNVRL | 7.7 | 1.5329 | No | Nontoxin | |
|
| ||||||
| H2-Dd | 4-15 | YSAVFPGFSSSF | 0.58 | 0.4492 | No | Nontoxin |
| 6-17 | LSTFLPGAKKEW | 4.7 | 0.0692 | Yes | Nontoxin | |
| 48-59 | GHPDDKQVTCVV∗ | 4.7 | 1.7670 | No | Nontoxin | |
| 24-35 | ITVNPENNGVTL | 5.5 | 1.3534 | No | Nontoxin | |
| 26-37 | VNPENNGVTLIC | 6.7 | 1.0295 | No | Nontoxin | |
|
| ||||||
| H2-Kb | 10-21 | VAHCAYSSNVRL∗ | 2.7 | 1.5329 | No | Nontoxin |
| 31-42 | SVNRSVSVFALL | 4.0 | -0.3061 | No | Toxin | |
| 4-15 | YSAVFPGFSSSF | 5.1 | 0.4492 | No | Nontoxin | |
| 6-17 | AVFPGFSSSFWT | 7.9 | 0.8884 | No | Nontoxin | |
| 32-43 | VNRSVSVFALLF | 9.3 | 0.1617 | No | Nontoxin | |
|
| ||||||
| H2-Kd | 24-35 | SYVALSAASLTA | 2.9 | 0.4534 | No | Nontoxin |
| 4-15 | YSAVFPGFSSSF | 6.0 | 0.4492 | No | Nontoxin | |
| 33-44 | EHYPATSKAFRV | 6.1 | 0.3313 | No | Nontoxin | |
| 33-44 | DQFPSTAQTIYL | 6.6 | -0.0877 | No | Toxin | |
| 31-42 | PKDQFPSTAQTI | 7.0 | 0.1665 | No | Nontoxin | |
|
| ||||||
| H2-Kk | 25-36 | TVNPENNGVTLI∗ | 1.4 | 0.9366 | No | Nontoxin |
| 17-28 | DACDELPSYVAL | 1.6 | 0.1381 | Yes | Nontoxin | |
| 3-14 | ETGGENGDSPVL | 3.1 | 1.1581 | Yes | Nontoxin | |
| 33-44 | DQFPSTAQTIYL | 3.9 | -0.0877 | No | Toxin | |
| 15-26 | KEWVTGTLQQGI | 4.9 | 1.2743 | No | Nontoxin | |
|
| ||||||
| H2-Ld | 36-47 | LPSKLLSEDDGL | 0.42 | 0.0641 | Yes | Nontoxin |
| 22-33 | LPSYVALSAASL | 0.92 | 0.2773 | No | Nontoxin | |
| 24-35 | ITVNPENNGVTL | 1.2 | 1.3534 | No | Nontoxin | |
| 11-22 | SPVLRGDACDEL∗ | 1.3 | 1.3596 | No | Nontoxin | |
| 22-33 | RPITVNPENNGV | 1.7 | 1.3057 | Yes | Nontoxin | |
|
| ||||||
| H-2-Qa1 | 4-15 | YSAVFPGFSSSF | 2.1 | 0.4492 | No | Nontoxin |
| 17-28 | ALVYDSQHSITF | 3.3 | 0.4102 | No | Nontoxin | |
| 33-44 | VTLICGPDGKAF | 5.1 | 0.4982 | Yes | Nontoxin | |
| 24-35 | ITVNPENNGVTL | 5.4 | 1.3534 | No | Nontoxin | |
| 5-16 | SAVFPGFSSSFW∗ | 5.4 | 1.0065 | No | Nontoxin | |
|
| ||||||
| H-2-Qa2 | 25-36 | TVNPENNGVTLI | 2.5 | 0.9366 | No | Nontoxin |
| 15-26 | KEWVTGTLQQGI∗ | 3.1 | 1.2743 | No | Nontoxin | |
| 17-28 | ALVYDSQHSITF | 3.1 | 0.4102 | No | Nontoxin | |
| 33-44 | DQFPSTAQTIYL | 4.1 | -0.0877 | No | Toxin | |
| 3-14 | ETGGENGDSPVL | 5.3 | 1.1581 | Yes | Nontoxin | |
∗ indicates potential high-ranked, antigenic, nonallergenic, and nontoxic epitopes.
Prediction of mouse MHC-II-binding epitopes of N. caninum SRS2 using IEDB server followed by screening for antigenicity, allergenicity, toxicity, and IFN-γ/IL-4 induction.
| Mouse MHC-II alleles | Position | T-cell peptide | Percentile rank | VaxiJen antigenicity score | AllergenFP allergenicity prediction | ToxinPred toxicity prediction | IFN- | IL-4 induction |
|---|---|---|---|---|---|---|---|---|
| H2-IAb | 23-37 | PSYVALSAASLTATA | 1.1 | 0.4796 | No | Nontoxin | Positive | Negative |
| 22-36 | LPSYVALSAASLTAT | 1.21 | 0.3898 | No | Nontoxin | Positive | Negative | |
| 24-38 | SYVALSAASLTATAI | 1.41 | 0.4271 | No | Nontoxin | Positive | Negative | |
| 21-35 | ELPSYVALSAASLTA | 1.5 | 0.4580 | No | Nontoxin | Negative | Negative | |
| 25-39 | YVALSAASLTATAIF | 1.76 | 0.3833 | No | Nontoxin | Negative | Negative | |
| 2-34 | DELPSYVALSAASLT | 1.85 | 0.2164 | No | Nontoxin | Negative | Negative | |
|
| ||||||||
| H2-IAd | 20-34 | DELPSYVALSAASLT | 0.64 | 0.2164 | No | Nontoxin | Negative | Negative |
| 21-35 | ELPSYVALSAASLTA | 0.73 | 0.4580 | No | Nontoxin | Negative | Negative | |
| 22-36 | LPSYVALSAASLTAT | 0.73 | 0.3898 | No | Nontoxin | Positive | Negative | |
| 23-37 | PSYVALSAASLTATA | 0.98 | 0.4796 | No | Nontoxin | Positive | Negative | |
| 24-38 | SYVALSAASLTATAI | 1.39 | 0.4271 | No | Nontoxin | Positive | Negative | |
| 19-33 | CDELPSYVALSAASL | 1.59 | 0.3479 | No | Nontoxin | Negative | Positive | |
|
| ||||||||
| H2-IEd | 1-15 | MATHACVVRRKADAA | 1.99 | -0.3581 | No | Nontoxin | Negative | Negative |
| 2-16 | ATHACVVRRKADAAC | 2.75 | -0.5192 | Yes | Nontoxin | Negative | Positive | |
| 12-26 | HCAYSSNVRLRPITV∗ | 3.00 | 1.3421 | No | Nontoxin | Positive | Negative | |
| 11-25 | AHCAYSSNVRLRPIT∗ | 3.35 | 1.4654 | No | Nontoxin | Positive | Negative | |
| 3-17 | THACVVRRKADAACF | 3.9 | -0.6533 | Yes | Nontoxin | Negative | Positive | |
| 10-24 | VAHCAYSSNVRLRPI∗ | 4.1 | 1.3060 | No | Nontoxin | Positive | Negative | |
∗ indicates high-ranked, antigenic, and nonallergenic epitopes with potential IFN-γ induction.
Prediction of top ten cytotoxic T-lymphocyte (CTL) epitopes of N. caninum SRS2 using CTLpred web server with antigenicity, allergenicity, and hydrophobicity screening.
| Rank | Start position | Peptide sequence | Score (ANN/SVM) | VaxiJen antigenicity score | AllergenFP allergenicity prediction | Hydrophobicity (%) |
|---|---|---|---|---|---|---|
| 1 | 194 | AYSSNVRLR∗ | 0.57/1.3921456 | 1.6339 | No | 33.33 |
| 2 | 70 | GNADQWVAL | 0.57/1.1068306 | 0.4913 | No | 55.56 |
| 3 | 374 | LRGDACDEL∗ | 0.90/0.57070616 | 1.5932 | No | 33.33 |
| 4 | 182 | RESEVIGQV∗ | 0.61/0.78029309 | 1.5955 | No | 33.33 |
| 5 | 228 | YMNHHCTEL | 0.65/0.73549537 | 0.4257 | No | 22.22 |
| 6 | 127 | STFLPGAKK | 0.93/0.44198631 | 0.1985 | Yes | 44.44 |
| 7 | 1 | MATHACVVR | 0.82/0.53762368 | 0.0049 | No | 55.56 |
| 8 | 328 | KRDGEQVNK | 0.82/0.44522211 | 1.3420 | No | 11.11 |
| 9 | 28 | TAKSVNRSV | 0.61/0.65066346 | 0.2242 | No | 33.33 |
| 10 | 102 | SEDDGLIVC∗ | 0.65/0.59971526 | 1.9440 | No | 33.33 |
∗ indicates antigenic, nonallergenic, and hydrophobic CTL epitopes.